Mccormick Frank
BridgeBio Pharma, Inc. - Common Stock · Director
Mccormick Frank is listed in filings as Director at BridgeBio Pharma, Inc. - Common Stock. This profile follows SEC Form 4 activity through Oct 31, 2025, including sale activity. Recent filings connect the profile to BridgeBio Pharma, Inc. - Common Stock (BBIO) and BridgeBio Oncology Therapeutics Inc. (BBOT). The current snapshot covers public activity from May 9, 2025 to Oct 31, 2025. Reported amounts are shown as $7.3M to $2.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $107k1.6k shares | SellOct 27, 2025 | $65.00 | $81.46 | |
| $4M74k shares | SellSep 5, 2025 | $53.16 | $81.46 | |
| $4M100k shares | SellJun 24, 2025 | $44.23 | $81.46 |